Manuscripts
February 28, 2025
Biomarker testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data
JTO Clinical and Research Reports
Behera M
January 31, 2025
Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer
Bladder Cancer Advocacy Network
Callihan, EB
December 19, 2024
Racial disparities in clinical trial enrollment among patients diagnosed with prostate cancer: A population-based cohort of oncology practices
Advances in Urology
Wiesen BM et al
November 21, 2024
Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database
Prostate Cancer and Prostatic Diseases
Eule CJ et al
August 26, 2024
Treatment intensification in metastatic hormone-sensitive prostate cancer: An analysis of real-world practice patterns from the CancerLinQ database
Urologic Oncology
Eule CJ et al
June 25, 2024
EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis
Future Oncology
Muthusamy B et al
June 19, 2024
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
Cancer Medicine
Sukumar JS et al
June 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer
NPJ Breast Cancer
Johnson KCC et al
March 28, 2024
Seeking American Society of Clinical Oncology-Quality Oncology Practice Initiative (ASCO-QOPI) certification in a northern New England rural health system and cancer care network
Learning Health Systemas
Perrey HM et al
Abstracts
January 31, 2025
Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer
Bladder Cancer Advocacy Network
Eryn C
December 10, 2024
Social determinants of health (SDOH) and Z code utilization among patients with breast cancer (BC)
SABC 2024
Jones N et al
December 10, 2024
Disparities in second breast cancer events and survival persist despite optimal treatment in hormone-receptor positive breast cancer: Analysis of the real-world ASCO CancerLinQ dataset
SABC 2024
Kantor O et al
May 23, 2024
Electronic clinical quality measure (eCQM) concordance and quality care disparities among patients with breast cancer (BC).
ASCO Annual Meeting 2024
Jones N et al
May 23, 2024
Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis.
ASCO Annual Meeting 2024
Sohail Ahmed K et al
May 23, 2024
Disparities in patients with HER2-positive breast cancer receiving optimal treatment: Analysis of the real-world ASCO CancerLinQ dataset.
ASCO Annual Meeting 2024
Kantor O et al
May 1, 2024
MP51-18: Population-based trends and outcomes for cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States
AUA Annual Meeting 2024
Wiesen B et al
May 1, 2024
MP31-17: Variation in genomic testing amongst localized prostate cancer patients undergoing radical prostatectomy or radiation therapy: Results from a population-based cohort
AUA Annual Meeting 2024
Wiesen B et al
January 29, 2024
Patterns of concurrent chemotherapy selection in US patients undergoing trimodality therapy for muscle-invasive bladder cancer
ASCO Genitourinary Cancers Symposium 2024
Callihan E et al
